Argaw Nitsuh Alemayehu, Shumbash Kibruyisfawe Zewdie, Asfaw Alemseged Ayele, Hawaze Segewkal
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, P. O. Box 1176, Addis Ababa, Ethiopia.
Department of Surgery: Neurosurgery Unit, School of Medicine, College of Health Sciences, Addis Ababa University, P. O. Box 1176, Addis Ababa, Ethiopia.
BMC Res Notes. 2017 Apr 20;10(1):160. doi: 10.1186/s13104-017-2475-2.
Prophylactic antimicrobials have a starring role in prevention of surgical site infection. This study assesses the practice of surgical antimicrobial prophylaxis (SAP) and development of surgical site infection (SSI) based on patient chart review in patients who underwent surgery in the Orthopaedics and Traumatology Surgical Unit of Tikur Anbesa Specialized Hospital (TASH).
Majority of the patients 144 (72%) were males. 108 (54%) of the surgical wounds were clean and 63 (31%) were clean contaminated. 160 (80%) patients received preoperative prophylaxis, of these 153 (96%) received postoperative prophylaxis as well. 34 (17%) patients did not receive preoperative antimicrobial prophylaxis, while 6 (3%) patients had no record about preoperative antimicrobial prophylaxis. Among those who received preoperative antimicrobial prophylaxis the time of administration was not recorded in 87 (54%) of the patient charts and 36 (23%) patients had preoperative antimicrobial prophylaxis greater than 2 h prior to incision. Among the 188 (94%) patients that received postoperative antimicrobial prophylaxis; the duration of administration was more than 72 h in 114 (61%) patients, while only 8 (4%) received for less than 24 h after surgery. Ceftriaxone 309 (70%) was the most prescribed agent for prophylaxis. 32 (16%) patients developed surgical site of infection. Using odds ratio age equal to or above 50, clean contaminated and contaminated surgical wounds were not statistically associated with increased risk of SSI.
Most patients who underwent surgery received prophylactic antimicrobials; nevertheless, the practice was not aligned with standard guidelines' recommendations and patients developed surgical site infections.
预防性抗菌药物在预防手术部位感染中起着关键作用。本研究通过回顾提库尔·安贝萨专科医院(TASH)骨科与创伤外科接受手术患者的病历,评估手术抗菌药物预防(SAP)的实施情况及手术部位感染(SSI)的发生情况。
大多数患者144例(72%)为男性。108例(54%)手术切口为清洁切口,63例(31%)为清洁-污染切口。160例(80%)患者接受了术前预防,其中153例(96%)也接受了术后预防。34例(17%)患者未接受术前抗菌药物预防,6例(3%)患者无术前抗菌药物预防记录。在接受术前抗菌药物预防的患者中,87例(54%)的病历未记录给药时间,36例(23%)患者术前抗菌药物预防在切口前超过2小时。在188例(94%)接受术后抗菌药物预防的患者中,114例(61%)给药持续时间超过72小时,而术后仅8例(4%)接受预防少于24小时。头孢曲松309例(70%)是预防用药中最常开具的药物。32例(16%)患者发生了手术部位感染。使用比值比分析,年龄等于或大于50岁、清洁-污染和污染手术切口与SSI风险增加无统计学关联。
大多数接受手术的患者接受了预防性抗菌药物治疗;然而,实际做法未符合标准指南的建议,且患者发生了手术部位感染。